Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response...
Saved in:
Published in | Cell Vol. 181; no. 5; pp. 1036 - 1045.e9 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
28.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.
[Display omitted]
•SARS-CoV-2 infection induces low IFN-I and -III levels with a moderate ISG response•Strong chemokine expression is consistent across in vitro, ex vivo, and in vivo models•Low innate antiviral defenses and high pro-inflammatory cues contribute to COVID-19
In comparison to other respiratory viruses, SARS-CoV-2 infection drives a lower antiviral transcriptional response that is marked by low IFN-I and IFN-III levels and elevated chemokine expression, which could explain the pro-inflammatory disease state associated with COVID-19. |
---|---|
AbstractList | Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19. Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19. • SARS-CoV-2 infection induces low IFN-I and -III levels with a moderate ISG response • Strong chemokine expression is consistent across in vitro , ex vivo , and in vivo models • Low innate antiviral defenses and high pro-inflammatory cues contribute to COVID-19 In comparison to other respiratory viruses, SARS-CoV-2 infection drives a lower antiviral transcriptional response that is marked by low IFN-I and IFN-III levels and elevated chemokine expression, which could explain the pro-inflammatory disease state associated with COVID-19. Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19. Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19. [Display omitted] •SARS-CoV-2 infection induces low IFN-I and -III levels with a moderate ISG response•Strong chemokine expression is consistent across in vitro, ex vivo, and in vivo models•Low innate antiviral defenses and high pro-inflammatory cues contribute to COVID-19 In comparison to other respiratory viruses, SARS-CoV-2 infection drives a lower antiviral transcriptional response that is marked by low IFN-I and IFN-III levels and elevated chemokine expression, which could explain the pro-inflammatory disease state associated with COVID-19. |
Author | Hoagland, Daisy Albrecht, Randy A. Panis, Maryline Wang, Taia T. Møller, Rasmus Nilsson-Payant, Benjamin E. Sachs, David Schwartz, Robert E. tenOever, Benjamin R. Blanco-Melo, Daniel Liu, Wen-Chun Uhl, Skyler Jordan, Tristan X. Oishi, Kohei Lim, Jean K. |
Author_xml | – sequence: 1 givenname: Daniel surname: Blanco-Melo fullname: Blanco-Melo, Daniel organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 2 givenname: Benjamin E. surname: Nilsson-Payant fullname: Nilsson-Payant, Benjamin E. organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 3 givenname: Wen-Chun surname: Liu fullname: Liu, Wen-Chun organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 4 givenname: Skyler surname: Uhl fullname: Uhl, Skyler organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 5 givenname: Daisy surname: Hoagland fullname: Hoagland, Daisy organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 6 givenname: Rasmus surname: Møller fullname: Møller, Rasmus organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 7 givenname: Tristan X. surname: Jordan fullname: Jordan, Tristan X. organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 8 givenname: Kohei surname: Oishi fullname: Oishi, Kohei organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 9 givenname: Maryline surname: Panis fullname: Panis, Maryline organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 10 givenname: David surname: Sachs fullname: Sachs, David organization: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 11 givenname: Taia T. surname: Wang fullname: Wang, Taia T. organization: Divison of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA – sequence: 12 givenname: Robert E. surname: Schwartz fullname: Schwartz, Robert E. email: res2025@med.cornell.edu organization: Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA – sequence: 13 givenname: Jean K. surname: Lim fullname: Lim, Jean K. email: jean.lim@mssm.edu organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 14 givenname: Randy A. surname: Albrecht fullname: Albrecht, Randy A. email: randy.albrecht@mssm.edu organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – sequence: 15 givenname: Benjamin R. surname: tenOever fullname: tenOever, Benjamin R. email: benjamin.tenoever@mssm.edu organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32416070$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUlLxEAQhRtRdFz-gAfJ0UtidafTC4ggMy4DguB2bTqdUntI0mM6M-C_N8EFvUkd6lAfrx7v7ZLNNrRIyCGFjAIVJ4vMYV1nDBhkwDNgYoNMKGiZcirZJpkAaJYqIfkO2Y1xAQCqKIptspMzTgVImJCLeVPa2rYOq-Q6xD65w7gMbcSkD8n9-d19Og1PKUtmnV9jTGa4xjosG2z7JDwn09un-Sylep9sPds64sHX3iOPlxcP0-v05vZqPj2_SZEL1qcSLEiLpdKqYoXQuc2FBlmWggFFSq1wJchccSyxoFWuKq54gRooR-2cy_fI2afuclU2WLnBRmdrs-x8Y7t3E6w3fy-tfzUvYW0kY7JQYhA4_hLowtsKY28aH8cUbYthFQ3juR5GgfoHCuNIIQf06LetHz_fMQ_A6SeAQzhrj52JzuMYuu_Q9aYK3lAwY6tmYcYnZmzVADdDq_kHFxaT0A |
ContentType | Journal Article |
Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. 2020 Elsevier Inc. |
Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. – notice: 2020 Elsevier Inc. 2020 Elsevier Inc. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.1016/j.cell.2020.04.026 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1097-4172 |
EndPage | 1045.e9 |
ExternalDocumentID | PMC7227586 32416070 S009286742030489X |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: HHSN272201400008C – fundername: NIAID NIH HHS grantid: R01 AI123155 – fundername: NIDDK NIH HHS grantid: R01 DK121072 – fundername: NIAID NIH HHS grantid: R01 AI076471 – fundername: NIAID NIH HHS grantid: R01 AI139119 – fundername: NIAID NIH HHS grantid: R01 AI110575 – fundername: NIAID NIH HHS grantid: U19 AI111825 – fundername: NIAID NIH HHS grantid: R01 AI145882 – fundername: NIAID NIH HHS grantid: T32 AI007647 – fundername: NIAID NIH HHS grantid: R21 AI149033 |
GroupedDBID | --- --K -DZ -ET -~X 0R~ 0WA 1RT 1~5 29B 2FS 2WC 3EH 4.4 457 4G. 53G 5GY 5RE 62- 6I. 6J9 7-5 85S AACTN AAEDW AAFTH AAFWJ AAIAV AAKRW AAKUH AALRI AAUCE AAVLU AAXUO ABCQX ABJNI ABMAC ABMWF ABOCM ABVKL ACGFO ACGFS ACNCT ADBBV ADEZE ADJPV AEFWE AENEX AEXQZ AFTJW AGHSJ AGKMS AHHHB AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL CS3 DIK DU5 E3Z EBS F5P FCP FDB FIRID HH5 IH2 IHE IXB J1W JIG K-O KOO KQ8 L7B LX5 M3Z M41 N9A O-L O9- OK1 P2P RCE RNS ROL RPZ SCP SDG SDP SES SSZ TAE TN5 TR2 TWZ UKR UPT VQA WH7 WQ6 YZZ ZA5 ZCA AAEDT AAHBH AAMRU AAYWO ABDGV ACVFH ADCNI ADVLN ADXHL AEUPX AFPUW AGCQF AIGII AKAPO AKBMS AKRWK AKYEP APXCP CGR CUY CVF ECM EFKBS EIF NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-e462t-70a07aeb898d25693a36907bb6201e11a6cb07384ebe51d38d4845e9014e9ccc3 |
IEDL.DBID | IXB |
ISSN | 0092-8674 1097-4172 |
IngestDate | Thu Aug 21 13:56:45 EDT 2025 Fri Jul 11 07:43:22 EDT 2025 Fri Jul 11 02:05:24 EDT 2025 Mon Jul 21 05:50:52 EDT 2025 Fri Feb 23 02:48:23 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | COVID-19 SARS-CoV-2 IL6 Coronavirus virus-host interactions transcriptomics interferon chemokines ferret |
Language | English |
License | Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-e462t-70a07aeb898d25693a36907bb6201e11a6cb07384ebe51d38d4845e9014e9ccc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact These authors contributed equally |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S009286742030489X |
PMID | 32416070 |
PQID | 2404040767 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7227586 proquest_miscellaneous_2439393808 proquest_miscellaneous_2404040767 pubmed_primary_32416070 elsevier_sciencedirect_doi_10_1016_j_cell_2020_04_026 |
PublicationCentury | 2000 |
PublicationDate | 2020-05-28 |
PublicationDateYYYYMMDD | 2020-05-28 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cell |
PublicationTitleAlternate | Cell |
PublicationYear | 2020 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Corman, Landt, Kaiser, Molenkamp, Meijer, Chu, Bleicker, Brünink, Schneider, Schmidt (bib6) 2020; 25 Kamitani, Narayanan, Huang, Lokugamage, Ikegami, Ito, Kubo, Makino (bib20) 2006; 103 Witten, Tibshirani, Hastie (bib48) 2009; 10 García-Sastre, Egorov, Matassov, Brandt, Levy, Durbin, Palese, Muster (bib12) 1998; 252 Lazear, Schoggins, Diamond (bib26) 2019; 50 Wolfel, Corman, Guggemos, Seilmaier, Zange, Muller, Niemeyer, Jones, Vollmar, Rothe (bib49) 2020 Cui, Li, Shi (bib7) 2019; 17 Lokugamage, Hage, Schindewolf, Rajsbaum, Menachery (bib30) 2020 Harcourt, Tamin, Lu, Kamili, Sakthivel, Murray, Queen, Tao, Paden, Zhang (bib15) 2020 Zhu, Zhang, Wang, Li, Yang, Song, Zhao, Huang, Shi, Lu (bib53) 2020; 382 Law, Cheung, Ng, Sia, Chan, Luk, Nicholls, Peiris, Lau (bib25) 2005; 106 Hallak, Collins, Knudson, Peeples (bib14) 2000; 271 Szklarczyk, Gable, Lyon, Junge, Wyder, Huerta-Cepas, Simonovic, Doncheva, Morris, Bork (bib43) 2019; 47 (bib36) 2020; 41 Frieman, Baric (bib9) 2008; 72 tenOever (bib44) 2016; 19 Menachery, Eisfeld, Schäfer, Josset, Sims, Proll, Fan, Li, Neumann, Tilton (bib33) 2014; 5 Blanco-Melo, Nilsson-Payant, Uhl, Escudero-Pèrez, Olschewski, Thibault, Panis, Rosenthal, Muñoz-Fontela, Lee (bib2) 2020 Xu, Shi, Wang, Zhang, Huang, Zhang, Liu, Zhao, Liu, Zhu (bib51) 2020; 8 Sokol, Luster (bib42) 2015; 7 Norelli, Camisa, Barbiera, Falcone, Purevdorj, Genua, Sanvito, Ponzoni, Doglioni, Cristofori (bib35) 2018; 24 Lu, Zhang, Du, Zhang, Li, Qu, Zhang, Wang, Bao, Li (bib32) 2020 Love, Huber, Anders (bib31) 2014; 15 García-Sastre (bib11) 2017; 22 Varble, Albrecht, Backes, Crumiller, Bouvier, Sachs, García-Sastre, tenOever (bib45) 2014; 16 Weiss, Navas-Martin (bib46) 2005; 69 Wu, Zhao, Yu, Chen, Wang, Song, Hu, Tao, Tian, Pei (bib50) 2020; 579 Langmead, Salzberg (bib24) 2012; 9 Montecino-Rodriguez, Berent-Maoz, Dorshkind (bib34) 2013; 123 Sharma, tenOever, Grandvaux, Zhou, Lin, Hiscott (bib41) 2003; 300 Langlois, Albrecht, Kimble, Sutton, Shapiro, Finch, Angel, Chua, Gonzalez-Reiche, Xu (bib23) 2013; 31 Liao, Liu, Yuan, Wen, Xu, Zhao, Chen, Li, Wang, Wang (bib28) 2020 Channappanavar, Fehr, Vijay, Mack, Zhao, Meyerholz, Perlman (bib3) 2016; 19 Proudfoot (bib38) 2002; 2 Giavridis, van der Stegen, Eyquem, Hamieh, Piersigilli, Sadelain (bib13) 2018; 24 Pascal, Coleman, Mujica, Kamat, Badithe, Fairhurst, Hunt, Strein, Berrebi, Sisk (bib37) 2015; 112 Hur (bib17) 2019; 37 Wickham (bib47) 2016 Kim, Kim, Kim, Kim, Park, Yu, Chang, Kim, Lee, Casel (bib21) 2020 Yoshida, Lareau, Ramirez, Rose, Maier, Wroblewska, Desland, Chudnovskiy, Mortha, Dominguez (bib52) 2019; 176 de Wit, van Doremalen, Falzarano, Munster (bib8) 2016; 14 Jing, Shaheen, Drake, Chen, Gravenstein, Deng (bib19) 2009; 70 Chen, Zhou, Dong, Qu, Gong, Han, Qiu, Wang, Liu, Wei (bib4) 2020; 395 Janeway, Medzhitov (bib18) 2002; 20 Lefrançais, Ortiz-Muñoz, Caudrillier, Mallavia, Liu, Sayah, Thornton, Headley, David, Coughlin (bib27) 2017; 544 Amanat, Krammer (bib1) 2020; 52 Qin, Zhou, Hu, Zhang, Yang, Tao, Xie, Ma, Shang, Wang (bib40) 2020 Qian, Travanty, Oko, Edeen, Berglund, Wang, Ito, Holmes, Mason (bib39) 2013; 48 Liu, Nachbagauer, Stadlbauer, Solórzano, Berlanda-Scorza, García-Sastre, Palese, Krammer, Albrecht (bib29) 2019; 10 Frieman, Chen, Morrison, Whitmore, Funkhouser, Ward, Lamirande, Roberts, Heise, Subbarao, Baric (bib10) 2010; 6 Kopecky-Bromberg, Martínez-Sobrido, Frieman, Baric, Palese (bib22) 2007; 81 Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler, Erichsen, Schiergens, Herrler, Wu, Nitsche (bib16) 2020; 181 Chu, Pan, Cheng, Hui, Krishnan, Liu, Ng, Wan, Yang, Wang (bib5) 2020; 66 |
References_xml | – volume: 106 start-page: 2366 year: 2005 end-page: 2374 ident: bib25 article-title: Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells publication-title: Blood – year: 2020 ident: bib30 article-title: SARS-CoV-2 is sensitive to type I interferon pretreatment publication-title: bioRxiv – volume: 271 start-page: 264 year: 2000 end-page: 275 ident: bib14 article-title: Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection publication-title: Virology – volume: 81 start-page: 548 year: 2007 end-page: 557 ident: bib22 article-title: Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists publication-title: J. Virol. – volume: 69 start-page: 635 year: 2005 end-page: 664 ident: bib46 article-title: Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus publication-title: Microbiol. Mol. Biol. Rev. – volume: 52 start-page: 583 year: 2020 end-page: 589 ident: bib1 article-title: SARS-CoV-2 Vaccines: Status Report publication-title: Immunity – year: 2020 ident: bib21 article-title: Infection and rapid transmission of SARS-CoV-2 in ferrets publication-title: Cell Host Microbe – volume: 300 start-page: 1148 year: 2003 end-page: 1151 ident: bib41 article-title: Triggering the interferon antiviral response through an IKK-related pathway publication-title: Science – volume: 15 start-page: 550 year: 2014 ident: bib31 article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 publication-title: Genome Biol. – volume: 181 start-page: 271 year: 2020 end-page: 280.e8 ident: bib16 article-title: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor publication-title: Cell – volume: 112 start-page: 8738 year: 2015 end-page: 8743 ident: bib37 article-title: Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection publication-title: Proc. Natl. Acad. Sci. USA – volume: 31 start-page: 844 year: 2013 end-page: 847 ident: bib23 article-title: MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies publication-title: Nat. Biotechnol. – volume: 72 start-page: 672 year: 2008 end-page: 685 ident: bib9 article-title: Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation publication-title: Microbiol. Mol. Biol. Rev. – volume: 37 start-page: 349 year: 2019 end-page: 375 ident: bib17 article-title: Double-Stranded RNA Sensors and Modulators in Innate Immunity publication-title: Annu. Rev. Immunol. – volume: 7 year: 2015 ident: bib42 article-title: The chemokine system in innate immunity publication-title: Cold Spring Harb. Perspect. Biol. – volume: 10 start-page: 515 year: 2009 end-page: 534 ident: bib48 article-title: A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis publication-title: Biostatistics – volume: 14 start-page: 523 year: 2016 end-page: 534 ident: bib8 article-title: SARS and MERS: recent insights into emerging coronaviruses publication-title: Nat. Rev. Microbiol. – volume: 123 start-page: 958 year: 2013 end-page: 965 ident: bib34 article-title: Causes, consequences, and reversal of immune system aging publication-title: J. Clin. Invest. – volume: 9 start-page: 357 year: 2012 end-page: 359 ident: bib24 article-title: Fast gapped-read alignment with Bowtie 2 publication-title: Nat. Methods – volume: 544 start-page: 105 year: 2017 end-page: 109 ident: bib27 article-title: The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors publication-title: Nature – volume: 50 start-page: 907 year: 2019 end-page: 923 ident: bib26 article-title: Shared and Distinct Functions of Type I and Type III Interferons publication-title: Immunity – volume: 395 start-page: 507 year: 2020 end-page: 513 ident: bib4 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet – volume: 24 start-page: 739 year: 2018 end-page: 748 ident: bib35 article-title: Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells publication-title: Nat. Med. – volume: 6 start-page: e1000849 year: 2010 ident: bib10 article-title: SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism publication-title: PLoS Pathog. – volume: 25 start-page: 25 year: 2020 ident: bib6 article-title: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR publication-title: Euro Surveill. – volume: 47 start-page: D607 year: 2019 end-page: D613 ident: bib43 article-title: STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets publication-title: Nucleic Acids Res. – volume: 48 start-page: 742 year: 2013 end-page: 748 ident: bib39 article-title: Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 382 start-page: 727 year: 2020 end-page: 733 ident: bib53 article-title: A Novel Coronavirus from Patients with Pneumonia in China, 2019 publication-title: N. Engl. J. Med. – volume: 8 start-page: 420 year: 2020 end-page: 422 ident: bib51 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir. Med. – year: 2020 ident: bib32 article-title: SARS-CoV-2 Infection in Children publication-title: N. Engl. J. Med. – volume: 176 start-page: 897 year: 2019 end-page: 912.e20 ident: bib52 article-title: The cis-Regulatory Atlas of the Mouse Immune System publication-title: Cell – volume: 5 year: 2014 ident: bib33 article-title: Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses publication-title: MBio – year: 2020 ident: bib49 article-title: Virological assessment of hospitalized patients with COVID-2019 publication-title: Nature – volume: 20 start-page: 197 year: 2002 end-page: 216 ident: bib18 article-title: Innate immune recognition publication-title: Annu. Rev. Immunol. – volume: 41 start-page: 145 year: 2020 end-page: 151 ident: bib36 article-title: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China publication-title: Zhonghua Liu Xing Bing Xue Za Zhi – year: 2020 ident: bib15 article-title: Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States publication-title: Emerg. Infect. Dis. – volume: 66 start-page: 549 year: 2020 end-page: 555 ident: bib5 article-title: Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia publication-title: Clin. Chem. – volume: 17 start-page: 181 year: 2019 end-page: 192 ident: bib7 article-title: Origin and evolution of pathogenic coronaviruses publication-title: Nat. Rev. Microbiol. – year: 2016 ident: bib47 article-title: ggplot2: Elegant Graphics for Data Analysis – volume: 24 start-page: 731 year: 2018 end-page: 738 ident: bib13 article-title: CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade publication-title: Nat. Med. – year: 2020 ident: bib40 article-title: Dysregulation of immune response in patients with COVID-19 in Wuhan, China publication-title: Clin. Infect. Dis. – volume: 70 start-page: 777 year: 2009 end-page: 784 ident: bib19 article-title: Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood publication-title: Hum. Immunol. – volume: 579 start-page: 265 year: 2020 end-page: 269 ident: bib50 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature – volume: 22 start-page: 176 year: 2017 end-page: 184 ident: bib11 article-title: Ten Strategies of Interferon Evasion by Viruses publication-title: Cell Host Microbe – year: 2020 ident: bib28 article-title: The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing publication-title: medRxiv – year: 2020 ident: bib2 article-title: An inability to maintain the ribonucleoprotein genomic structure is responsible for host detection of negative-sense RNA viruses publication-title: bioRxiv – volume: 19 start-page: 181 year: 2016 end-page: 193 ident: bib3 article-title: Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice publication-title: Cell Host Microbe – volume: 16 start-page: 691 year: 2014 end-page: 700 ident: bib45 article-title: Influenza A virus transmission bottlenecks are defined by infection route and recipient host publication-title: Cell Host Microbe – volume: 10 start-page: 756 year: 2019 ident: bib29 article-title: Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model publication-title: Front. Immunol. – volume: 2 start-page: 106 year: 2002 end-page: 115 ident: bib38 article-title: Chemokine receptors: multifaceted therapeutic targets publication-title: Nat. Rev. Immunol. – volume: 252 start-page: 324 year: 1998 end-page: 330 ident: bib12 article-title: Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems publication-title: Virology – volume: 19 start-page: 142 year: 2016 end-page: 149 ident: bib44 article-title: The Evolution of Antiviral Defense Systems publication-title: Cell Host Microbe – volume: 103 start-page: 12885 year: 2006 end-page: 12890 ident: bib20 article-title: Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation publication-title: Proc. Natl. Acad. Sci. USA |
SSID | ssj0008555 |
Score | 2.7379358 |
Snippet | Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information... |
SourceID | pubmedcentral proquest pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1036 |
SubjectTerms | animal models Animals Betacoronavirus - physiology blood serum Cells, Cultured chemokines Chemokines - genetics Chemokines - immunology Coronavirus Coronavirus infections Coronavirus Infections - genetics Coronavirus Infections - immunology COVID-19 Disease Models, Animal ferret Host-Pathogen Interactions Humans IL6 Immunity, Innate inflammation Inflammation - virology interferon interferons Interferons - genetics Interferons - immunology interleukin-6 pandemic Pandemics patients Pneumonia, Viral - genetics Pneumonia, Viral - immunology RNA Viruses - classification RNA Viruses - immunology SARS-CoV-2 transcription (genetics) Transcription, Genetic transcriptomics virus-host interactions viruses |
Title | Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 |
URI | https://dx.doi.org/10.1016/j.cell.2020.04.026 https://www.ncbi.nlm.nih.gov/pubmed/32416070 https://www.proquest.com/docview/2404040767 https://www.proquest.com/docview/2439393808 https://pubmed.ncbi.nlm.nih.gov/PMC7227586 |
Volume | 181 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA4iCF7Et-uLCF6DbZqkyVF3V1YPCr7YW0jTFFewXbQe_PfOtF3ZVfAgObXJoZlJvplpvpkQcmqk44X3EeNxUEwYBzhojGc69wow06MJRrbFjRo9iuuxHC-R_iwXBmmVHfa3mN6gdffmrJPm2XQywRxfw7WC0A5P97QZAw4nQjdJfOOLbzTWUra3GBjY-TC6S5xpOV74cxxiRB415U6xwMKcRfrtcf4kTs5Zost1sta5kPS8_coNshTKTbLSXir5uUWGV68Z8hVhanRUvdf0rqXBBlpX9P787p71qyfG6eANK87SOdYQrQrav326GrDYbJPHy-FDf8S6yxJYEIrXLI1clLqQaaNzcGNM4hIMfLNMgYkPceyUz2A7awFak3Ge6FxoIQOeogbjvU92yHJZlWGP0CwtgnNCJsZJsF2FK3KtdABPpvCZz2WPyJmU7IKuLMCwndHGXixK16J0bSQsSLdHTmYitbCIsduVofp4t-BWYEtV-teYxEDTke6R3VYNdtpW5LDgFWKhvKhH0gUFfQ_AItqLPeXkuSmmnXIOIZPa_-ecDsgqPiGfgOtDsly_fYQjcFPq7LhZh1-aOeSD |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB3xIQSXqrRQthTqSr1aJE7s2EdYQLuUUokv7c1yHEddJJIVhEP_fWc2WbQLEgeUW-xDPGO_eRM_jwF-GulE6X3ERRwUT41DHDTGc114hZjpKQST2uJCDW7Ss5EcLUF_dhaGZJUd9reYPkXr7s1BZ82DyXhMZ3yN0ApTO9rd02a0DKvIBjJancPR0TMcaynbawwMLn3s3p2caUVe9Hcck0QRTeudUoWFuZD0mnK-VE7OhaLTj_Ch45DssP3MTVgK1SdYa2-V_PcZTob3OQkWcWxsUD827LLVwQbW1Ozq8PKK9-tbLtjxA5WcZXOyIVaXrP_ndnjMY7MFN6cn1_0B725L4CFVouFZ5KLMhVwbXSCPMYlLKPPNc4UxPsSxUz7H9axTdJuMi0QXqU5loG3UYLz3yTasVHUVdoDlWRmcS2VinMTgVbqy0EoHpDKlz30heyBnVrILzrKIw3amG7uzZF1L1rVRatG6PfgxM6nFWUzNrgr106NFXkFPprK3-iQGHx3pHnxp3WAnbUkOi7SQKuVFPcgWHPTcgapoL7ZU47_TatqZEJgzqa_vHNN3WB9c_z6358OLX7uwQS0kLhD6G6w0D09hDzlLk-9P5-R_If3now |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imbalanced+Host+Response+to+SARS-CoV-2+Drives+Development+of+COVID-19&rft.jtitle=Cell&rft.au=Blanco-Melo%2C+Daniel&rft.au=Nilsson-Payant%2C+Benjamin+E&rft.au=Liu%2C+Wenjun&rft.au=Uhl%2C+Skyler&rft.date=2020-05-28&rft.issn=0092-8674&rft.volume=181&rft.issue=5+p.1036-1045.e9&rft.spage=1036&rft.epage=1045&rft_id=info:doi/10.1016%2Fj.cell.2020.04.026&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0092-8674&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0092-8674&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0092-8674&client=summon |